Avantor, Inc.
- Jurisdiction
United States - ISIN
US05352A1007 (AVTR )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€12.78 7.4% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. Read full profile
Fundamentals
- Net revenue
€5.69B - Gross margin
33.2% - EBIT
€886.13M - EBIT margin
15.6% - Net income
€586.32M - Net margin
10.3%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| SUMME GREGORY L | N/A |
|
|
|
|
| Eck Steven W | SVP & Chief Accounting Officer |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Gilbert Cisneros | September 12, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | August 14, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
| John James | September 6, 2024 | $1.00K–$15.00K |